Stockscreener 앱 받기
3.62
3.13%
0.11
시간 외 거래:
3.45
-0.17
-4.70%
Engene Holdings Inc 주식(ENGN)의 최신 뉴스
What makes enGene Holdings Inc. stock price move sharplyFree Access to Community - Newser
How enGene Holdings Inc. Equity Warrant stock performs during market volatilityChart Breakout Alert - Newser
What makes enGene Holdings Inc. Equity Warrant stock price move sharplyFree AI-Powered Stock Predictions - Newser
Why enGene Holdings Inc. stock attracts strong analyst attentionChart Based Entries - Newser
Why enGene Holdings Inc. Equity Warrant stock attracts strong analyst attentionFree Market Sentiment Analysis - Newser
How enGene Holdings Inc. stock performs during market volatilityTrade With Low Risk Exposure - Newser
(ENGN) Trading Advice - news.stocktradersdaily.com
enGene Announces Board and Leadership Appointments to Support Commercial Readiness - Business Wire
enGene Holdings Expands Board with New Appointments - TipRanks
FDA grants RMAT designation to enGene’s bladder cancer therapy - Investing.com Australia
(ENGN) Investment Analysis - news.stocktradersdaily.com
enGene Holdings: Looking For An End To The 2025 Decline (Downgrade) (NASDAQ:ENGN) - Seeking Alpha
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) to four newly-hired employees - BioSpace
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
enGene Awards $1.3M in Stock Options to New Commercial Chief Amy Pott - Stock Titan
JMP reiterates market outperform rating on enGene stock on clinical progress By Investing.com - Investing.com Nigeria
JMP reiterates market outperform rating on enGene stock on clinical progress - Investing.com Australia
Engene stock maintains buy rating at H.C. Wainwright on LEGEND trial - Investing.com
enGene Holdings Inc. adopts new employee stock plan By Investing.com - Investing.com Nigeria
enGene Holdings Reports Q2 2025 Financial Results - TipRanks
Engene stock maintains Outperform rating at Raymond James on strong execution By Investing.com - Investing.com South Africa
Engene stock maintains Outperform rating at Raymond James on strong execution - Investing.com India
EnGene Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2025 - MarketScreener
enGene Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
enGene Holdings Inc reports results for the quarter ended April 30Earnings Summary - TradingView
EnGene Reports Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com
enGene Holdings Inc. SEC 10-Q Report - TradingView
enGene Holdings CMO Resignation Announced - MSN
enGene Holdings Approves 2025 Employee Stock Purchase Plan - TipRanks
enGene Holdings Inc. adopts new employee stock plan - Investing.com
ENGENE HOLDINGS Earnings Preview: Recent $ENGN Insider Trading, Hedge Fund Activity, and More - Nasdaq
enGene Holdings Expands with New Boston Lease - TipRanks
(ENGN) On The My Stocks Page - news.stocktradersdaily.com
enGene CMO Dr. Raj Pruthi to step down mid-June By Investing.com - Investing.com India
EnGene Chief Medical Officer Raj Pruthi to Step Down - marketscreener.com
enGene CMO Dr. Raj Pruthi Resigns - citybiz
enGene (ENGN) CMO Raj Pruthi Steps Down | ENGN Stock News - GuruFocus
enGene CMO Dr. Raj Pruthi to step down mid-June - Investing.com
enGene Announces the Resignation of its Chief Medical Officer - Business Wire
enGene to Present at the Jefferies Global Healthcare Conference - BioSpace
enGene appoints new Chief Global Commercialization Officer By Investing.com - Investing.com South Africa
enGene Names Amy Pott as Chief Global Commercialization Officer - citybiz
enGene appoints new Chief Global Commercialization Officer - Investing.com Australia
enGene (ENGN) Appoints Amy Pott as New Chief Global Commercialization Officer | ENGN Stock News - GuruFocus
EnGene Names Amy Pott As Chief Global Commercialization Officer - marketscreener.com
3.40%
2.49%
자본화:
|
볼륨(24시간):